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ABSTRACT
We reported a 15-year-old Japanese girl with possible
eosinophilic pneumonia (EP) from inhaled Alternaria.
She presented with a fever, cough and general fatigue
and with a moderate infiltrate in the right lower to
middle lung fields on a chest roentgenogram one
week previously. On admission, the above infiltrate
had disappeared, while a left upper infiltrate had
appeared. Eosinophilic pneumonia (EP) was diag-
nosed by a cytological study of bronchoalveolar
lavage fluid and histology of a transbronchial lung
biopsy. Skin test to and specific serum IgE antibody
against Alternaria were both positive. An inhaled
Alternaria challenge test showed both immediate and
late phase allergic reactions as evidenced by %FEV1.
In addition, Alternaria was significantly detected in all
places of the patient’s house. Alternaria could be a
causative organism of EP and should always be
considered one of its etiologic agents.
Key words: Alternaria, bronchoprovocation test,
eosinophilic pneumonia.
INTRODUCTION
Eosinophilic pneumonia (EP) refers to a poorly under-
stood and ill-defined group of disorders that are marked
by infiltrations of the lung by eosinophils with or without
an excess of these cells in the peripheral blood.1 Alter-
naria commonly causes bronchial asthma and allergic
rhinitis.2–4 It is also considered to be a causative antigen
of hypersensitivity pneumonitis.5 However, only one case
of eosinophilic pneumonia caused by Alternaria has been
cited in the literature.6 We report here a case of possible
eosinophilic pneumonia from inhaled Alternaria.
CLINICAL SUMMARY
A 15-year-old girl was referred to us in mid-August 1994
for further evaluation and treatment of low-grade fever and
general fatigue. One month prior to admission the patient
gradually developed fever, cough and general fatigue
after undertaking regular house-cleaning, which included
cleaning the filters of an air conditioner. Pulmonary infil-
trates in the right middle and left upper lobes were then
found on a chest roentgenogram (Fig. 1, left). The girl was
placed on an antibiotic but the symptoms persisted until
admission. Personal history was negative for bronchial
asthma. Family history disclosed that the patient’s mother
had suffered from pollen allergy for the previous 10 years.
The family had cared for no pet animals or birds. The
patient’s room was covered with a carpet on Japanese
matting (tatami). Her wooden house was built 20 years
before and did not have any roof leaks.
On admission the patient weighed 47 kg and mea-
sured 147 cm. Her pulse was 72 b.p.m., temperature
37.5°C, respiratory rate 16/min and blood pressure
108/68 mmHg. No signs of anemia, jaundice or cyanosis
were observed.
Fine crackling rales were audible in the left upper lung
field. Pulmonary function tests showed a percentage forced
vital capacity (%FVC) of 92.2 and a forced expiratory
volume in 1’s (FEV1) percentage of 94.8. Leukocyte count
was 10 400/ m L with 48% polymorphonuclear cells, 21%
eosinophils (an absolute count of 2184/ m L), 26% lympho-
cytes and 5% monocytes. The erythrocyte sedimentation
rate was 73 mm/h, while c-reactive protein (CRP) was
0.5 mg/dL and total serum immunoglobulin E (IgE) level
was 267.6 IU/mL. Peripheral lymphocyte subsets were
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normal. Stool parasitic ova were negative. Serum myco-
plasma pneumonia antibody, antinuclear antibody, antigen-
specific IgE antibody against Candida albicans and
Aspergillus fumigatus were negative. A skin test to and
specific IgE antibody against Alternaria were both posi-
tive (Table 1). Precipitating-antibody to Alternaria kiku-
chiana (100 ng/mL) measured by double-immunodiffusion
assay was also positive, but that to Aspergillus fumigatus
(100 ng/mL) was negative.7
To confirm the diagnosis of eosinophilic pneumonia,
bronchoscopy was performed after informed consent was
obtained from the patient and her parents. Bronchoalveolar
lavage (BAL) fluid yielded a cell count of 6.6 x 105 /mL, with
47.8% eosinophils, 29.6% macrophages, 20.5% lympho-
cytes and 1.1% neutrophils. Bronchoalveolar lavage fluid,
sputum, urine and blood cultures were sterile. A trans-
bronchial lung biopsy specimen showed severe thickening
of the bronchial basement membrane and increased inter-
stitial connective tissue with mild eosinophilic infiltration
(Fig. 2). On a chest roentgenogram, a right middle lobe
infiltrate had disappeared, whereas a left upper lobe infil-
trate had appeared (Fig. 1, right). Computed tomography
of the chest showed a dense consolidation in the left upper
lobe (Fig. 3).
Nineteen days after admission we carried out an
antigen challenge test according to the guidelines of
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Fig. 2 Histology of a transbronchial lung biopsy specimen
showing severe thickening of the bronchial basement mem-
brane and increased interstitial connective tissue with mild
eosinophilic infiltration.
Fig. 1 Chest roentgenogram 2 weeks prior to admission demonstrated small dense infiltrates in the right middle and left upper
lobes (left). On admission, a small dense consolidation appeared in the left upper lobe (right).
Table 1. Specific RAST IgE and skin prick test (SPT) against
fungal antigens 
* More than score 3; ** more than twice of control solution; RAST,
radioallergosorbent test.
RAST SPT
Alternaria +* +**
Aspergillus – –
Candida albicans – –
Shapiro.8 Briefly, the antigen was delivered by an ultra-
sonic nebulizer (Omuron, Tokyo, Japan) with an initial
inhalation of 1:1010 dilution of the Alternaria kikuchiana
solution (10 mg/mL, Torii Chemical Co. Ltd, Tokyo,
Japan) in a dose of 2 mL. Pulmonary functions were
measured 10 min after the antigen inhalation. Figure 4
showed changes of %FVC and %FEV1, which decreased
from 75.9% to 66.5% and 76% to 61% after the anti-
gen inhalation (1:106 dilution), respectively, and then
returned to initial levels after a salbutamol inhalation.
Nine hours after the antigen challenge, %FVC and
%FEV1 reduced to 57.5% and 45%, respectively, when
moist rales became audible and severe cough appeared.
As %FVC and %FEV1 did not recover even after the
second salbutamol inhalation, hydrocortisone was given.
Twelve hours after the challenge test, %FVC and %FEV1
returned to normal levels.
From the sterile Petri dishes containing Sabouraud’s
culture medium supplemented with antibiotics, which
were exposed for 10 min at several places in the patient’s
house, Alternaria was significantly found in all places
(Table 2). No other fungi were detected in these places
(Table 2).
Oral corticosteroid therapy was initiated with 1 mg/kg
of prednisolone. As both infiltration and eosinophilia dis-
appeared 1 week later, prednisolone was then tapered
and withdrawn. To protect the recurrence, beclometha-
sone inhalation was continued for 6 months and then
disodium chromoglycate inhalation therapy was under-
taken for 2 years and 6 months. Three years after onset
the patient was free of symptoms, although specific IgE
antibodies against Alternaria still remained positive. No
infiltration was seen on chest roentgenograms.
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Fig. 3 Computed tomography of the chest on admission
showed a dense consolidation in the left lobe.
Fig. 4 An antigen challenge
test was performed with an initial
inhalation dose of 1:100 dilution
of the Alternaria kikuchianas
extract solution (concentration:
10 mg/mL, Torii Chemical Co.
Ltd, Tokyo, Japan) used in
the prick test. (h), %FVC;
(r), %FEV1; (s), SaO2. %FEV1
decreased at a concentration of
1 : 106 of the Alternaria antigen
solution and then 9 h later it
markedly reduced. a, salbutamol
inhalation; b, intravenous hydro-
cortisone (500 mg)
DISCUSSION
We presented a case of possible eosinophilic pneumonia
from Alternaria of a 15-year-old Japanese girl. The
patient was diagnosed as having EP because of her
symptoms and BAL findings. However, in the present case
we should carefully rule out another disease. Because
some patients with hypersensitivity pneumonitis (HP) show
BOOP (bronchiolitis obliterans organizing pneumonia)
patterns on chest roentogenograms, our case was con-
sidered to be a variant of HP.9 However, BOOP shows
the distinct histologic and BAL findings, as opposed to
eosinophilic pneumonia, and so it is possible that our
case is not a BOOP.10
It is difficult to clearly distinguish eosinophilic pneumonia
and allergic bronchopulmonary alternariosis (ABPAI) in this
case. However, according to diagnostic criteria of allergic
bronchopulmonary aspergillosis (ABPA),11 the present case
could hardly be diagnosed ABPAl because of the non-
elevated IgE and the lack of an asthma history. Further study
is needed in order to establish what constitutes the diag-
nostic criteria of ABPAl.
The patient demonstrated positive responses in the
prick test and specific IgE antibody. Complete response
of oral corticosteroid and no relapse of symptoms were
observed. Both BAL and sputum were negative for fungal
cultures. Therefore, Alternaria is unlikely to have caused
fungal pneumonia in the present case.
In addition, we excluded a number of etiologic factors
that could have produced EP. No drug had been pre-
scribed before the onset and no pathogenic organisms
were detected in any sample obtained from our patient.
Aspergillus was not considered to be a causative agent
because both specific IgE and a prick test against Asper-
gillus were negative.
Although the pathogenesis of EP is still unknown,
Badesch et al. indicate that it may be related to a hyper-
sensitive phenomenon to an inhaled antigen.12 In our
case, the symptoms started after the patient undertook
general house-cleaning. Further, Alternaria was also
significantly found in her house when compared with other
fungi. Usually, general house-cleaning is performed every
season in Japan. Therefore, it is thought that a large
quantity of inhaled Alternaria antigen was scattered in the
house and provoked eosinophilic pneumonia.
On discharge, we advised the patient to clean up her
house and to inhale beclomethasone to prevent the
recurrence of EP. In her house a large quantity of
Alternaria antigen was considered to be constantly
present, although inhaled beclomethasone may be
considered as being effective in inhibiting the production
of cytokines and chemokines such as interleukin (Il)-5
and IL-8 superfamily regulated on activation normal
T-expressed and secreted (RANTES).
Greenberger11 advocated that patients with EP should
be divided into four types: (i) acute (less than 5 days’
duration); (ii) chronic (insidious onset); (iii) simple (Löffler
syndrome); and (iv) tropical (from filariasis). Many cases
of simple eosinophilic pneumonia are likely to be due to
parasitic infections or medications. Acute EP is charac-
terized by acute respiratory failure with diffuse pulmonary
infiltrates. However, patients with chronic eosinophilic
pneu-monia (CEP) can present peripheral infiltrates in the
distal two-thirds of the lung fields. The present case
was classified as CEP because of the persistent symp-
toms, findings of chest roentgenograms and computed
tomographic scans, and a complete response to corticos-
teroid hormone.
In the antigen bronchoprovocation test the dual airway
response was observed as being associated with clinical
symptoms such as cough and rale. However, fever, ele-
vated CRP and elevated eosinophils were not observed
on the next day of the test. As the patient had a severe
cough and showed decreased pulmonary function 9 h
after the onset, we prescribed hydrocortisone to treat
clinical symptoms. Therefore, the steroid hormone was
considered to inhibit Arthus-type allergic reaction.
Bronchial asthma is characterized by eosinophilic infil-
tration of the bronchi and bronchioles,13 whereas the
features of eosinophilic pneumonia are eosinophilic
infiltration in the interstitium and the small air spaces of
the lung.14 In a primate model of allergic broncho-
pulmonary aspergillosis, Slavin et al. reported that the
occurence of the characteristic eosinophilic infiltration
may need the association of both IgG and IgE antibodies
to aspergillus.15 In the present case, the occurrence of the
disease may be related to both IgE and IgG antibodies
to Alternaria, although it is difficult to clearly distinguish
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Table 2. Distribution of fungus in the house of the patient by
the method of sedimentation on a mycological medium
Location Fungus type
At the side of the
telephone Alternaria 4* Penicillium 1* Yeast 8*
In the rest room Alternaria 4* Penicillium 1* Yeast 8*
On the corridor Alternaria 2*
On the patient’s desk Alternaria 3*
* numbers of colony
between EP and ABPAl, as already discussed. Further
study is needed to elucidate why Alternaria causes EP.
Alternaria should be considered to be one of the etio-
logic agents of eosinophilic pneumonia.
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